BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2692357)

  • 21. [Comparison between EEG-finding and clinical picture in patients with Parkinsonism under L-dopa].
    Bengesser G
    Wien Med Wochenschr; 1975 Feb; 125(7-8):120-1. PubMed ID: 1146347
    [No Abstract]   [Full Text] [Related]  

  • 22. [Tiapride in persistent dyskinesias following long-term L-dopa for parkinsonism].
    Arlazoroff A; Flechtir S; Goldexberg E; Bleicher Z; Barber Y
    Harefuah; 1985 Mar; 108(5):227-9. PubMed ID: 4007677
    [No Abstract]   [Full Text] [Related]  

  • 23. Malignant melanoma and levodopa.
    Rosin MA; Braun M
    Cutis; 1984 Jun; 33(6):572-4. PubMed ID: 6744949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Twenty-two cutaneous primary melanomas in a patient with high genetic predisposition to melanoma receiving levodopa therapy for Parkinson's disease.
    Charles J; Templier I; Leroux D; Salameire D; Robert C; Lantuejoul S; Leccia MT
    Pigment Cell Melanoma Res; 2009 Dec; 22(6):851-3. PubMed ID: 19708914
    [No Abstract]   [Full Text] [Related]  

  • 25. Lid melanoma and parkinsonism.
    Haider SA; Thaller VT
    Br J Ophthalmol; 1992 Apr; 76(4):246-7. PubMed ID: 1390497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [L-dopa-induced psychoses and their treatment with L-tryptophan].
    Demling J
    Fortschr Med; 1986 Apr; 104(17):360-2. PubMed ID: 3710403
    [No Abstract]   [Full Text] [Related]  

  • 27. [L-dopa therapy for Parkinsonism and its relationship to surgical methods of treatments].
    Vasin NIa; Il'inskiĭ IA; Safronov VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(5):701-6. PubMed ID: 4454895
    [No Abstract]   [Full Text] [Related]  

  • 28. L-dopa-resistant Parkinsonism due to dopa decarboxylase deficiency?
    Jankovic J
    Ann Neurol; 1981 Jul; 10(1):64-5. PubMed ID: 7271235
    [No Abstract]   [Full Text] [Related]  

  • 29. Levodopa in the early treatment of Parkinson's disease.
    Murata M
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S17-20. PubMed ID: 19131036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of Parkinson's disease: levodopa as the first choice.
    Katzenschlager R; Lees AJ
    J Neurol; 2002 Sep; 249 Suppl 2():II19-24. PubMed ID: 12375059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of parkinsonism by dopaflex (L-DOPA).
    Grbesa B; Velicković A
    Ther Hung; 1977; 25(3):106-8. PubMed ID: 929475
    [No Abstract]   [Full Text] [Related]  

  • 32. Uveal malignant melanoma and levodopa therapy in Parkinson's disease.
    Van Rens GH; De Jong PT; Demols EE; Brihaye-Van Geertruyden MF
    Ophthalmology; 1982 Dec; 89(12):1464-6. PubMed ID: 7162789
    [No Abstract]   [Full Text] [Related]  

  • 33. [L-Dopa].
    Benoit P; Peutillot A
    Soins; 1985 Apr; (452):I-II. PubMed ID: 3848106
    [No Abstract]   [Full Text] [Related]  

  • 34. [Early or late onset of L-dopa treatment in Parkinson disease?].
    von Kummer R; Schneevoigt K
    Nervenarzt; 1986 Nov; 57(11):634-9. PubMed ID: 3808131
    [No Abstract]   [Full Text] [Related]  

  • 35. [L-dopa in the therapy of Parkinson's disease today].
    Piccinin GL; Piccirilli M; Morocutti C
    Clin Ter; 1982 Jan; 100(2):189-202. PubMed ID: 6764620
    [No Abstract]   [Full Text] [Related]  

  • 36. Levodopa effective parkinsonism associated with aqueductal stenosis: a case report and review of the literature.
    Asamoto S; Sugiyama H; Doi H; Yokochi M; Hirabayashi K; Tanaka S; Sugiura K; Nakama H; Matsumoto K
    No Shinkei Geka; 1998 Dec; 26(12):1089-92. PubMed ID: 9883448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Onset-and end-of-dose dyskinesias induced by L-dopa treatment in a patient with juvenile parkinsonism].
    Katsuki T; Shimizu N; Mizuno Y
    No To Shinkei; 1984 Dec; 36(12):1201-5. PubMed ID: 6529518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The "on-off" response to chronic L-DOPA treatment of Parkinsonism.
    Sweet RD; McDowell FH
    Adv Neurol; 1974; 5():331-8. PubMed ID: 4440581
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment strategies in Parkinson's disease after a quarter century experiences with L-DOPA therapy.
    Fischer PA
    J Neural Transm Suppl; 1995; 46():381-9. PubMed ID: 8821073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Trans-cerebral electrophoresis of L-DOPA in the complex treatment of parkinsonism].
    Neĭmark EZ; Evtushenko SK; Dukhovnaia MA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1334-8. PubMed ID: 6506979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.